Mead, S;
Khalili-Shirazi, A;
Potter, C;
Mok, T;
Nihat, A;
Hyare, H;
Canning, S;
... Collinge, J; + view all
(2022)
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme.
The Lancet Neurology
, 21
(4)
pp. 342-354.
10.1016/S1474-4422(22)00082-5.